Request Your Free White Paper Now:

"Accessing special populations: Considerations for lactation studies during drug development"

Explore the importance of making clinical trials more accessible for those who breastfeed

Breastfeeding, touted for its numerous benefits, often intersects with the need for taking medications. This intersection poses a complex challenge that requires careful study and understanding. A significant percentage of postpartum individuals need to take at least one medication, and since many of these medications can be secreted into breast milk, it is crucial to understand if the benefits of treating the medical condition outweigh the potential risk of drug exposure to the breastfed infant.

This white paper explores:

• the importance of conducting lactation studies during drug development programs for comprehensive drug impact understanding
• the role of regulatory bodies in fostering inclusivity
• unique barriers to participation
• strategies for boosting participation in clinical trials

Offered Free by: PPD
See All Resources from: PPD